International Physical Medicine & Rehabilitation Journal,
Год журнала:
2022,
Номер
7(2), С. 100 - 104
Опубликована: Окт. 6, 2022
Each
day
brings
more
devastating
news
about
the
spread
of
HIV/AIDS.HIV
survives
in
latent
cellular
and
anatomical
reservoirs,
rendering
current
treatments
useless.Currently,
most
cutting-edge
antiretrovirals
(ARVs)
cocktail
are
used
HIV/AIDS
treatment.The
only
thing
ARVs
can
do
is
keep
virus
under
control
stop
it
from
spreading.Because
this,
those
living
with
HIV
at
risk
coexist
peacefully
normally.Nanomedicine
nanotechnology
as
a
strategy
to
defeat
desperately
needed.From
vantage
point
Nanoeduparemiology,
one
take
holistic
view
potential
solutions.This
incorporates
nanomedicine,
education,
paremiology,
all
which
rooted
many
religious
spiritual
traditions.Teachers
lecturers
transmit
eduparemiology
tactics
(education
through
proverbs
local
knowledge)
parents,
students,
society
large.
Abstract
Bacteria
extracellular
vesicles
(BEVs),
characterized
as
the
lipid
bilayer
membrane-surrounded
nanoparticles
filled
with
molecular
cargo
from
parent
cells,
play
fundamental
roles
in
bacteria
growth
and
pathogenesis,
well
facilitating
essential
interaction
between
host
systems.
Notably,
benefiting
their
unique
biological
functions,
BEVs
hold
great
promise
novel
nanopharmaceuticals
for
diverse
biomedical
potential,
attracting
significant
interest
both
industry
academia.
Typically,
are
evaluated
promising
drug
delivery
platforms,
on
account
of
intrinsic
cell-targeting
capability,
ease
versatile
engineering,
capability
to
penetrate
physiological
barriers.
Moreover,
attributing
considerable
immunogenicity,
able
interact
immune
system
boost
immunotherapy
nanovaccine
against
a
wide
range
diseases.
Towards
these
directions,
this
review,
we
elucidate
nature
role
activating
response
better
understanding
BEV-based
nanopharmaceuticals’
development.
Additionally,
also
systematically
summarize
recent
advances
achieving
target
genetic
material,
therapeutic
agents,
functional
materials.
Furthermore,
vaccination
strategies
using
carefully
covered,
illustrating
flexible
potential
combating
bacterial
infections,
viral
cancer.
Finally,
current
hurdles
further
outlook
will
be
provided.
Graphical
Bioconjugate Chemistry,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 20, 2025
Cardiovascular
diseases
remain
the
leading
cause
of
mortality
worldwide.
Specifically,
atherosclerosis
is
a
primary
acute
cardiac
events.
However,
current
therapies
mainly
focus
on
lipid-lowering
versus
addressing
underlying
inflammatory
response
that
leads
to
its
development
and
progression.
Nanoparticle-mediated
drug
delivery
offers
promising
approach
for
targeting
regulating
these
responses.
In
atherosclerotic
lesions,
cascades
result
in
increased
T
helper
(Th)
1
Th17
activity
reduced
regulatory
activation.
The
regulation
cell
responses
critical
preventing
imbalance
atherosclerosis,
making
them
key
therapeutic
target
nanotherapy
achieve
precise
treatment.
By
functionalizing
nanoparticles
with
modalities,
agents
can
be
delivered
specifically
immune
cells
lesions.
this
Review,
we
outline
role
examine
nanotherapeutic
strategies
modulating
their
differentiation,
provide
perspectives
tailored
treatment
atherosclerosis.
International Journal of Pharmaceutics,
Год журнала:
2023,
Номер
650, С. 123678 - 123678
Опубликована: Дек. 6, 2023
The
primary
objective
of
this
study
was
to
enhance
the
effectiveness
protease
inhibitor
antiretroviral
drug
by
designing
a
novel
delivery
system
using
carboxylated
multiwalled
carbon
nanotubes
(COOH-MWCNTs).
To
achieve
this,
Fosamprenavir
calcium
(FPV),
prodrug
amprenavir
known
for
inhibiting
proteolytic
cleavage
immature
virions,
selected
as
drug,
and
loaded
onto
COOH-MWCNTs
direct
loading
method.
structural
specificity
drug-loaded
MWCNTs,
percent
entrapment
efficiency,
in
vitro
release
were
rigorously
evaluated
developed
formulation,
referred
FPV-MWCNT.
Fourier
transform
infrared
(FTIR)
spectroscopy,
Field
emission
scanning
electron
microscopy
(FE-SEM),
Raman
atomic
force
(AFM)
techniques
employed
confirm
integrity
FPV-MWCNT
formulation.
results
demonstrated
remarkable
efficiency
79.57
±
0.4
%,
indicating
successful
FPV
COOH-MWCNTs.
FE-SEM
AFM
analyses
further
confirmed
well-dispersed
elongated
structure
without
any
signs
fracture,
ensuring
stability
system.
Moreover,
particle
size
analysis
revealed
an
average
290.1
nm,
firmly
establishing
nanoscale
range
with
zeta
potential
0.230
mV,
signifying
system's
colloidal
stability.
In
studies
conducted
methanolic
phosphate
buffer
saline
(PBS)
at
pH
7.4
acetate
5
sustained
from
Over
period
96
h,
formulation
exhibited
cumulative
91.43
2.3
showcasing
controlled
profile.
Furthermore,
hemolysis
indicated
notable
reduction
toxicity
both
MWCNT
upon
conjugation,
although
increased
higher
concentrations,
suggesting
need
careful
consideration
dosage
levels.
conclusion,
findings
underscore
effective
promising
drug-conjugated
delivering
drugs.
encapsulation,
release,
reduced
make
compelling
candidate
enhancing
therapeutic
efficacy
drugs
treatment
HIV.
holds
great
promise
future
advancements
HIV
paves
way
research
development
field
utilizing
nanotube-based
systems.
Nanomedicine,
Год журнала:
2025,
Номер
unknown, С. 1 - 17
Опубликована: Фев. 18, 2025
Substance
use
disorders
(SUD)
and
HIV-associated
neurocognitive
(HAND)
work
synergistically
as
a
significant
cause
of
cognitive
decline
in
adults
adolescents
globally.
Current
therapies
continue
to
be
limited
due
difficulties
crossing
the
blood-brain
barrier
(BBB)
leading
precision
effectiveness,
neurotoxicity,
lack
co-treatment
options
for
both
HAND
SUD.
Nanoparticle-based
therapeutics
have
several
advantages
over
conventional
including
more
precise
targeting,
ability
cross
BBB,
high
biocompatibility
which
decreases
toxicity
optimizes
sustainability.
These
extend
other
neurological
such
Alzheimer's
disease
(AD)
amyotrophic
lateral
sclerosis
(ALS).
This
review
summarizes
recent
advances
nanotechnology
application
HAND,
SUD,
co-treatment,
well
disorders.
also
highlights
potential
challenges
these
face
clinical
translation
long-term
safety.
IGI Global eBooks,
Год журнала:
2025,
Номер
unknown, С. 433 - 482
Опубликована: Май 9, 2025
Nanotechnology
is
a
multidisciplinary
field
that
manipulates
materials
at
the
nanoscale,
typically
between
1
and
100
nanometers.
It
bridges
various
disciplines,
including
physics,
chemistry,
biology,
engineering,
science,
creating
with
unique
properties
classical
theories
cannot
predict.
central
to
advancements
in
energy,
medical
therapies,
environmental
solutions,
electronics.
Nanotechnology's
ability
create
more
efficient
energy
storage
systems,
such
as
high-capacity
batteries,
its
potential
revolutionize
healthcare
by
enabling
personalized
medicine
further
demonstrate
vast
impact.
These
innovations
offer
solutions
pressing
issues
like
clean
health
care,
ecological
preservation.
This
chapter
focuses
on
green
synthesis
methods
plant
highlighting
environmentally
friendly
techniques
for
producing
nanomaterials.
sustainable
not
only
contribute
eco-friendly
agricultural
practices
but
also
promote
conservation
sustainability
of
nanotechnology.
Advances in medical diagnosis, treatment, and care (AMDTC) book series,
Год журнала:
2023,
Номер
unknown, С. 22 - 85
Опубликована: Ноя. 3, 2023
This
chapter
provides
a
comprehensive
review
of
recent
advances
in
nanomaterials
for
drug
delivery,
focusing
on
the
design
and
preparation
nanocarriers.
It
also
dissects
intricate
mechanisms
underpinning
loading
release,
delves
into
strategic
planning
inherent
achieving
target
delivery.
further
outlines
potential
applications
these
treating
various
diseases,
including
cancer,
infectious
neurological
disorders.
A
distinct
case
study
is
incorporated
chapter,
elucidating
promising
utility
electrospun
nanofibers
delivery
paradigms.
In
its
concluding
remarks,
engages
thoughtful
discourse
about
persistent
challenges
within
this
rapidly
evolving
field.
forecasts
trajectories
future
exploration
innovation
captivating
domain
Microbiology Research,
Год журнала:
2023,
Номер
14(1), С. 355 - 370
Опубликована: Март 8, 2023
Despite
the
use
of
highly
active
antiretroviral
therapy
approved
by
United
States
Food
and
Drug
Administration
(FDA)
for
treatment
human
immunodeficiency
virus
(HIV)
infection,
HIV
remains
a
public
health
concern
due
to
inability
eradicate
virus.
In
this
study,
N-methyl-N-phenyl
dithiocarbamate
complexes
indium(III),
bismuth(III),
antimony(III),
silver(I),
copper(II)
were
synthesized.
The
characterized
thermal
gravimetric
analysis
(TGA),
differential
scanning
calorimetry
(DSC),
Fourier
transform
infrared
spectroscopy
(FTIR).
then
evaluated
their
antiviral
effects
against
HIV-1
subtypes
A
(Q168),
B
(QHO.168),
C
(CAP210
ZM53).
results
showed
that
copper(II)-bis
(N-methyl-N-phenyl
dithiocarbamate)
complex
had
neutralization
efficiency
94%
CAP210,
54%
ZM53,
45%
Q168,
63%
QHO.168.
silver(I)-bis
minimal
HIV,
while
indium(III)
antimony(III)
no
activity
HIV-1.
findings
revealed
dithiocarbamate),
with
further
improvement,
could
be
explored
as
an
alternative
entry
inhibitor
HIV.